Nitrous Oxide - (N₂O)

How N2O Works to Treat Depression

Nitrous oxide (N₂O)—the same gas often called “laughing gas”—has been studied as a rapid-acting treatment for depression, especially treatment-resistant depression. It doesn’t work like traditional antidepressants, and that’s a big part of why it’s interesting.

Here’s the clear, science-level explanation

The core mechanism: NMDA receptor blockade

Nitrous oxide primarily works by blocking NMDA receptors, which are part of the brain’s glutamate system.

Glutamate is the brain’s main excitatory neurotransmitter
In depression, glutamate signaling can be dysregulated
NMDA receptors are one of glutamate’s main receptor types

By inhibiting NMDA receptors, nitrous oxide:

Reduces pathological overactivity in certain neural circuits
Triggers downstream changes that promote healthier signaling

This is very similar to ketamine, which is why researchers became interested in N₂O in the first place.

Rapid antidepressant effects (hours, not weeks)

Unlike SSRIs (which work over weeks), nitrous oxide can produce improvement within hours.

Why?

NMDA blockade causes a surge in AMPA receptor activity
This boosts brain-derived neurotrophic factor (BDNF)
BDNF promotes synaptic plasticity (the brain’s ability to rewire)

In simple terms:

Nitrous oxide helps the brain form new, healthier connections, especially in mood-regulating regions like the prefrontal cortex.

Effects on mood circuits

Nitrous oxide indirectly influences key brain areas involved in depression:

Prefrontal cortex → improves top-down emotional regulation
Limbic system (amygdala) → reduces negative emotional bias
Default mode network → may decrease rumination and self-focused negative thought loops

This helps explain why patients often report:

Less emotional heaviness
Reduced suicidal ideation
A sense of mental “relief” or clarity

Opioid and GABA involvement (secondary effects)

Nitrous oxide also:

Stimulates endogenous opioid release
Enhances GABAergic inhibition

These effects likely contribute to:

Short-term anxiolysis
Feelings of calm or mild euphoria

But these are not believed to be the primary antidepressant mechanism—the glutamate pathway is the star of the show.

How it’s administered in depression studies

Typically:

Low concentrations (e.g., 25–50% mixed with oxygen)
Single session, often ~1 hour
Effects can last days to weeks after one treatment

Importantly:

This is not recreational dosing
It’s done in controlled, medical settings
Most private payers and Medicare do not cover nitrous oxide for non-dental, non-surgical purpose